Delivery Order SPE2DB22D3501-SPE2DB25FWC34
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Lo Loestrin Fe 1/10 tablets in 28-count packaging. This is a firm fixed-price delivery order with a ceiling value of $1,226.80, with an ultimate completion date of November 18, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,160.66 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,245.48 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price contract represents a non-competitive award and serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle that runs through December 2026. The...
- The Defense Logistics Agency awarded a $2,198.43 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packages) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lo Loestrin Fe 1-10 tablets in 28-count packaging, with a ceiling value of $2,225.65. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work...
- The Defense Logistics Agency awarded a $2,386.52 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on May 20, 2025, with an ultimate completion date of May 21, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,599.91 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive pharmaceutical product. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, was awarded without set-aside restrictions through competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,042.64 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count units) on June 2, 2025, with an ultimate completion date of June 3, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.999 billion through December 2026. The order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. This firm fixed-price delivery order, valued at $1,497.08, represents a non-competitive award and is part of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The order is scheduled for completion by September 16, 2025, with performance occurring at the...
- The Defense Logistics Agency awarded a $4,039.86 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for Lo Loestrin Fe 1-10 tablets (quantity: 28-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 3, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWC34Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Lo Loestrin FE 1-10 tablets (28-count packaging) with a ceiling value of $3,613.04. This is a firm fixed-price delivery order with an ultimate completion date of June 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contraceptive medication being procured under this order supports the Defense Health Agency and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 6/20/25 |